购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

LDN-214117

Rating icon 很棒
产品编号 T1944Cas号 1627503-67-6

LDN214117 是一种高效的 ALK2 选择性抑制剂(IC50:22nM),也是一种 BMP6 抑制剂(IC50:100nM),对ALK5抑制力弱100倍。

LDN-214117
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

LDN-214117

Rating icon 很棒
纯度: 100%
产品编号 T1944Cas号 1627503-67-6

LDN214117 是一种高效的 ALK2 选择性抑制剂(IC50:22nM),也是一种 BMP6 抑制剂(IC50:100nM),对ALK5抑制力弱100倍。

规格价格库存数量
2 mg¥ 297现货
5 mg¥ 497现货
10 mg¥ 913现货
25 mg¥ 1,830现货
50 mg¥ 3,130现货
100 mg¥ 4,590现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"LDN-214117"的相关化合物库

选择批次:
纯度:99.85%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
LDN-214117 is a potent and selective ALK2 inhibitor.
靶点活性
ALK2:24 nM
体内活性
LDN-214117对BMP6比对BMP2或BMP4表现出相对的选择性抑制。在基于细胞的测定中,LDN-214117对BMP6表现出选择性抑制,IC50约为100 nM,作用于BMP6比作用于TGF-β1选择性高164倍。LDN-214117高度抑制的激酶为ALK2,IC50为24 nM,其次为TNIK,RIPK2和ABL1。LDN-214117选择性抑制ALK2和ALK1激酶活性,抑制作用高于ALK3激酶。
激酶实验
ALK2 kinase assay: Puri?ed recombinant ALK2 proteins, ATP, ATP[γ-32P], and dephosphorylated casein at ?nal concentrations of 2.5 nM, 6 μM, 0.05 μCi/μL , and 0.5 mg/mL, respectively, are aliquoted in kinase bu?er containing 0.2% BSA supplemented with 10 mM MnCl2 into 96-microwell plates, in combination with inhibitor compounds diluted at varying concentrations (0.01 nM to 100 μM). Positive control samples lacking inhibitor compounds, and negative controls lacking recombinant kinase, are also measured. The mixture is reacted at RT for 45 min, quenched with a ?nal concentration of 2% phosphoric acid. The reaction mixture is transferred to 96-well P81 phosphocellulose ?lter plates and bound for 5 min. The plates are washed 20 times with 150 μL of 1% phosphoric acid solution per well by vacuum manifold. Plates are dried at RT for 1 h, sealed, and assayed with Microscint 20 scintillation ?uid using a Spectramax L luminometer. Data is normalized to positive controls at 100% enzyme activity, with negative controls being subtracted as background.
细胞实验
Cells are seeded at 25000 cells per well in 96-well plates and incubated for 2 h at 37℃ and 5% CO2. Compounds of LDN-214117 or DMSO are diluted in DMEM and added at ?nal compound concentrations of 1, 10, and 100 μM. Cells are incubated for 4 and 24 h, after which the media is discarded. Cells are lysed by adding 30 μL of passive lysis bu?er and shaken at RT for 15 min. Cell viability is determined by quantifying the ATP present in each well by adding 10 μL of Cell Titer Glo per well and measuring the light output by Spectramax L luminometer. Data is normalized to 100% viability for cells receiving only DMSO.(Only for Reference)
化学信息
分子量419.52
分子式C25H29N3O3
CAS No.1627503-67-6
SmilesCOc1cc(cc(OC)c1OC)-c1cc(cnc1C)-c1ccc(cc1)N1CCNCC1
密度1.134 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
Ethanol: 42 mg/mL (100 mM)
DMSO: 4.2 mg/mL (10 mM), Sonication is recommended.
溶液配制表
1mg5mg10mg50mg
1 mM2.3837 mL11.9184 mL23.8368 mL119.1838 mL
5 mM0.4767 mL2.3837 mL4.7674 mL23.8368 mL
10 mM0.2384 mL1.1918 mL2.3837 mL11.9184 mL
1mg5mg10mg50mg
20 mM0.1192 mL0.5959 mL1.1918 mL5.9592 mL
50 mM0.0477 mL0.2384 mL0.4767 mL2.3837 mL
100 mM0.0238 mL0.1192 mL0.2384 mL1.1918 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy LDN-214117 | purchase LDN-214117 | LDN-214117 cost | order LDN-214117 | LDN-214117 chemical structure | LDN-214117 in vivo | LDN-214117 formula | LDN-214117 molecular weight